Follow us on

Language Selector

 
 
 
Italian Medicines Agency Agenzia Italiana del Farmaco

Medicines usable for treatment of COVID-19 disease

Medicines usable for treatment of COVID-19 disease

In this section AIFA provides updated information on medicines used outside clinical trials, such as those marketed for other indications which are made available to patients, even in the absence of a specific therapeutic indication for COVID-19, often based on rather limited scientific evidence. Precisely for the high level of uncertainty whereby these therapies are made available and considering the particular state of emergency with respect to a pandemic that we are learning to know day by day, it is deemed important to continuously update the information relating to the efficacy and safety tests which will gradually become available.

For this purpose, the Agency’s Scientific Technical Committee has prepared cards to make clear the therapeutic guidelines within which it is possible to provide for a controlled and safe use of the pharmaceuticals used in the context of this emergency. The cards clearly report evidence of efficacy and safety available as of today, the interactions and recommended methods of use in COVID-19 patients. In the same format, the medicines are listed whose use is recommended to remain within controlled clinical trials. In preparing such cards, the most updated evidence available at the time was taken into account.

Information sheets on drugs used for COVID-19 emergency and related prescription procedures

Recommendations on medicines to be used in home management of COVID-19 cases

Related links

AIFA communications

28/07/2023

Antivirals and monoclonal antibodies for COVID-19: the AIFA monitoring summary report is online

14/07/2023

Monitoring of antivirals for COVID-19: new report published

14/07/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

09/06/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

09/06/2023

Monitoring of antivirals for COVID-19: new report published

19/05/2023

Monitoring of antivirals for COVID-19: new report published

19/05/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

05/05/2023

Monitoring of antivirals for COVID-19: new report published

04/05/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

14/04/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

13/04/2023

Monitoring of antivirals for COVID-19: new report published

28/03/2023

Monitoring of antivirals for COVID-19: new report published

23/03/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

15/03/2023

Modifica Registro ANTIVIRALI ORALI COVID-19

10/03/2023

Monitoring of antivirals for COVID-19: new report published

09/03/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

24/02/2023

Monitoring of antivirals for COVID-19: new report published

23/02/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

09/02/2023

Monitoring of monoclonal antibodies for COVID-19: weekly report published

27/01/2023

Monitoring of antivirals for COVID-19: new report published

All news

Page 1 of 11
— 20 Items per Page
Showing 1 - 20 of 210 results.

Nested Applications

Press

Last tweets

📍 #AIFA sul territorio: a Genova la prossima tappa Dopo Milano e Palermo, AIFA fa tappa a Genova pe...
Vai al post →
🔬 Promuovere la cultura della ricerca clinica nella Medicina Generale È disponibile, online e gratu...
Vai al post →
💊 Farmacovigilanza attiva: bando per progetto nazionale dedicato a #pazienti anziani, multicronici ...
Vai al post →
From across Europe to Rome to discuss #OrphanMedicines and #RareDiseases The meeting of the Committ...
Vai al post →
📍AIFA partecipa alla nona edizione dei Seminari di Mogliano Veneto Due giornate di confronto sull’...
Vai al post →
📢 Il CdA di #AIFA dà il via libera alla rimborsabilità di 2 nuovi #farmaci orfani per il trattament...
Vai al post →

Go to Twitter profile

Multimedia

Medicina di precisione e appropriatezza prescrittiva

Go to YouTube channel

Cookie Bar

cookie management module

close and reject everything

Descrizione cookieBar

Questo sito utilizza cookie tecnici e analytics, necessari al suo funzionamento, per i quali non è richiesto il consenso. Per alcuni servizi aggiuntivi, le terze parti fornitrici, dettagliatamente sotto individuate, possono utilizzare cookies tecnici, analytics e di profilazione. Per saperne di più consulta la PRIVACY POLICY. Per proseguire nella navigazione devi effettuare la scelta sui cookie di terze parti dei quali eventualmente accetti l’utilizzo. Chiudendo il banner attraverso la X in alto a destra rifiuti tutti i cookie di terze parti. Puoi rivedere e modificare le tue scelte in qualsiasi momento attraverso il link "Gestione cookie" presente nel footer.

Social networks

Footer

go to beginning of content